CompletedNot Applicable

Myocardial Injury and Quality of Life After COVID-19

Russia119 participantsStarted 2020-09-16

Plain-language summary

In this observational study follow-up and dynamic observation will be conducted on the participants recovered from pneumonia caused by COVID-19. The main goal is an early diagnosis and detection of myocardial (heart) injury and quality of life in participants recovered from COVID-19 and follow-up in selected participants with present signs of myocarditis and/or myocardial fibrosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients of age above 18 years with diagnosed SARS-CoV-2 infection based on the PCR (polymerase chain reaction) and/or quantitative tests of IgM and IgG antibodies in serum; * Pneumonia development confirmed by chest computed tomography; * Negative PCR test for SARS-CoV-2 at the time of inclusion into the study; * Stable patient state allowing outpatient follow-up; * Signed informed consent. Exclusion Criteria: * Absence of convincing data confirming SARS-CoV-2 infection of a participant at the time of inclusion; * Absence of medical records regarding previous treatment of COVID-19; * Low compliance and unwillingness to undergo defined examinations; * Absence of informed consent.

What they're measuring

Percentage of Patients (%) Recovered From COVID-19 With a Decrease in the Global Contractility of the Left and Right Ventricles.

Timeframe: Up to 12 months

Proportion of Patients (%) Recovered From COVID-19 With Signs of Pericardial Effusion.

Timeframe: Up to 12 months

Proportion of Patients (%) Recovered From COVID-19 With Signs of Early and Late Gadolinium Enhancement of Myocardium.

Timeframe: Up to 12 months

Trial details

NCT IDNCT04794062

SponsorVoronezh Regional Clinical Consultative and Diagnostic Center

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2021-10-01

Results submitted2022-05-13

View on ClinicalTrials.gov More COVID-19 trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Percentage of Patients (%) Recovered From COVID-19 With a Decrease in the Global Contractility of the Left and Right Ventricles.

Timeframe: Up to 12 months

Proportion of Patients (%) Recovered From COVID-19 With Signs of Pericardial Effusion.

Timeframe: Up to 12 months

Proportion of Patients (%) Recovered From COVID-19 With Signs of Early and Late Gadolinium Enhancement of Myocardium.

Timeframe: Up to 12 months